- $11.86m
- $332.16m
- $751.10m
- 18
- 84
- 14
- 33
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.19 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.02 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -344.86% | ||
| Return on Equity | -200.69% | ||
| Operating Margin | -84.71% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | 295.76 | 631.13 | 751.1 | 815.79 | 987.2 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CareMax, Inc. is a technology-enabled care platform providing value-based care and chronic disease management through physicians and health care professionals committed to the overall health and wellness continuum of care for its patients. It operates over 56 centers and managed affiliated providers across 10 states that offer a suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States. Its CareOptimize is an end-to-end technology platform that aggregates and analyzes data using proprietary algorithms and machine learning to support more informed care delivery decisions and to focus care decisions on preventative chronic disease management and the social determinants of health. The Company offers 24/7 access to care through employed providers and provides a comprehensive suite of high-touch health care and social services for its patients.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 8th, 2020
- Public Since
- July 21st, 2020
- No. of Shareholders
- 71
- No. of Employees
- 1,450
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 3,802,883
- Address
- 1000 Nw 57Th Court, Suite 400, MIAMI, 33126
- Web
- https://www.caremax.com/
- Phone
- +1 3056863912
- Auditors
- PricewaterhouseCoopers LLP (USA)
Upcoming Events for CMAX
CareMax Inc Annual Shareholders Meeting
Q2 2024 CareMax Inc Earnings Release
Similar to CMAX
23andMe Holding Co.
NASDAQ Global Select Market
Acadia Healthcare
NASDAQ Global Select Market
Accolade
NASDAQ Global Select Market
Addus HomeCare
NASDAQ Global Select Market
Alignment Healthcare
NASDAQ Global Select Market
FAQ
What is the Caremax share price?
As of Today at 19:04 UTC, shares in Caremax are trading at $3.12. This share price information is delayed by 15 minutes.
How has the Caremax share price performed this year?
Shares in Caremax last closed at $3.12 and the price had moved by -95.86% over the past 365 days. In terms of relative price strength the Caremax share price has underperformed the S&P500 Index by -96.61% over the past year.
What are the analyst and broker recommendations for Caremax?
The overall consensus recommendation for Caremax is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Caremax dividend yield?
Caremax does not currently pay a dividend.
Does Caremax pay a dividend?
Caremax does not currently pay a dividend.
When does Caremax next pay dividends?
Caremax does not currently pay a dividend.
How do I buy Caremax shares?
To buy shares in Caremax you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Caremax?
As of the previous close price of $3.12, shares in Caremax had a market capitalisation of $11.86m.
Where are Caremax shares listed?
Here are the trading details for Caremax:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: CMAX
What kind of share is Caremax?
Based on an overall assessment of its quality, value and momentum Caremax is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Caremax share price forecast for 2024?
The analyst consensus target price for shares in Caremax is $33.60. That is 976.92% above the last closing price of $3.12.
Analysts covering Caremax currently have a consensus Earnings Per Share (EPS) forecast of -$16.80 for the next financial year.
What is the trend in the Caremax share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Caremax. Over the past six months, its share price has underperformed the S&P500 Index by -95.81%.
As of the last closing price of $3.12, shares in Caremax were trading -91.12% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Caremax PE Ratio?
The Caremax PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $3.12.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Caremax?
We do not have data on Caremax's directors